Evaluation of Point‐of‐Care Coagulation Measurement Systems for Activated Clotting Time and Partial Thromboplastin Time in Heparinized and Non‐Heparinized Equine Blood
Journal of Veterinary Emergency and Critical Care · 2026-05 · 36 (3) · 330-335
DOI: 10.1111/vec.70127 ↗At a glance
Journal article in Journal of Veterinary Emergency and Critical Care, published online on 2026-06-09. Written by Kallie J Hobbs and 5 co-authors. Institution: Department of Clinical Sciences, Texas A&M University, College Station, Texas, USA. Major MEDLINE topics: Point-of-Care Systems. 26 references. The full text is freely available in PubMed Central. Funded by: North Carolina State University Intramural Fund, Thoroughbred Education and Research Foundation Young Investigator Grant.
Abstract (original language)
Objectives
To compare the performance of one point‐of‐care activated clotting time (ACT) machine (Vet‐Tube), one point‐of‐care activated partial thromboplastin time (aPTT) machine (Coagulation DX), and one bench‐top ACT machine (Medtronic ACT II plus) with previously published measurements from stationary devices in whole blood from healthy horses.
Design
Prospective, observational study Setting University veterinary teaching hospital, from August 2023 to September 2023. Animals Thirty healthy university‐owned horses.
Methods
ACT and aPTT were measured via point‐of‐care analyzers (ACT POC, aPTT POC) and by conventional stationary analyzers (ACT Stationary, aPTT Stationary) in non‐heparinized and heparinized blood collected from healthy horses. Samples were analyzed within 30 min of collection.
Results
Moderate correlation ( r = 0.5), acceptable bias, and a low intraassay coefficient of variation (5%) were seen for the aPTT POC device, with the aPTT stationary device being within previously published ranges. The aPTT stationary chemistry analyzer and aPTT POC showed a significant difference for non‐heparinized samples ( n = 30, p = 0.0002) but had no significant difference for heparinized samples ( n = 15, p = 0.03). Clinical Relevance The results of this study provide proof of concept for the use of low‐cost POC monitoring of ACT in equine patients with coagulopathy or undergoing heparin therapy. Rigorous evaluation in patients with clinical disease is still necessary.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Sciences, Texas A&M University, College Station, Texas, USA.
- Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
Funding
- North Carolina State University Intramural Fund
- Thoroughbred Education and Research Foundation Young Investigator Grant
Cite
APA
Hobbs, K. J., Ueda, Y., Qu, Y., Cooper, B. L., Sheats, M. K., & Burke, M. J. (2026). Evaluation of Point‐of‐Care Coagulation Measurement Systems for Activated Clotting Time and Partial Thromboplastin Time in Heparinized and Non‐Heparinized Equine Blood. Journal of Veterinary Emergency and Critical Care, 36(3), 330-335. https://doi.org/10.1111/vec.70127
Vancouver
Hobbs KJ, Ueda Y, Qu Y, Cooper BL, Sheats MK, Burke MJ. Evaluation of Point‐of‐Care Coagulation Measurement Systems for Activated Clotting Time and Partial Thromboplastin Time in Heparinized and Non‐Heparinized Equine Blood. Journal of Veterinary Emergency and Critical Care. 2026;36(3):330-335. doi:10.1111/vec.70127
BibTeX
@article{Hobbs2026,
author = {Hobbs, Kallie J and Ueda, Yu and Qu, Yang and Cooper, Bethanie L and Sheats, M Katie and Burke, Megan J},
title = {Evaluation of Point‐of‐Care Coagulation Measurement Systems for Activated Clotting Time and Partial Thromboplastin Time in Heparinized and Non‐Heparinized Equine Blood},
journal = {Journal of Veterinary Emergency and Critical Care},
year = {2026},
volume = {36},
number = {3},
pages = {330--335},
doi = {10.1111/vec.70127}
}
EUVIMED